Invention Grant
- Patent Title: Serum albumin binding molecules
- Patent Title (中): 血清白蛋白结合分子
-
Application No.: US13098851Application Date: 2011-05-02
-
Publication No.: US08969289B2Publication Date: 2015-03-03
- Inventor: Michael L. Gosselin , David Fabrizio , Joanna F. Swain , Tracy Mitchell , Ray Camphausen , Sharon T. Cload , Eric Furfine , Paul E. Morin , Ranjan Mukherjee , Simeon I. Taylor
- Applicant: Michael L. Gosselin , David Fabrizio , Joanna F. Swain , Tracy Mitchell , Ray Camphausen , Sharon T. Cload , Eric Furfine , Paul E. Morin , Ranjan Mukherjee , Simeon I. Taylor
- Applicant Address: US NJ Princeton
- Assignee: Bristol-Myers Squibb Company
- Current Assignee: Bristol-Myers Squibb Company
- Current Assignee Address: US NJ Princeton
- Agency: Nelson Mullins Riley & Scarborough LLP
- Agent Jane E. Remillard, Esq.; Cynthia L. Kanik
- Main IPC: C07K14/00
- IPC: C07K14/00 ; A61K47/48 ; C12N15/62 ; C07K14/78 ; A61K38/00
Abstract:
The present invention relates to an antibody-like protein based on the tenth fibronectin type III domain (10Fn3) that binds to serum albumin. The invention further relates to fusion molecules comprising a serum albumin-binding 10Fn3 joined to a heterologous protein for use in diagnostic and therapeutic applications.
Public/Granted literature
- US20110305663A1 SERUM ALBUMIN BINDING MOLECULES Public/Granted day:2011-12-15
Information query
